SVENSKA CELLULO Valuation

SCA Stock   11.78  0.04  0.34%   
At this time, the company appears to be fairly valued. SVENSKA CELLULO B has a current Real Value of USD12.13 per share. The regular price of the company is USD11.78. Our model measures the value of SVENSKA CELLULO B from examining the company fundamentals such as return on equity of 0.076, and Price To Book of 1.08 X as well as evaluating its technical indicators and probability of bankruptcy.
Fairly Valued
Today
11.78
Please note that SVENSKA CELLULO's price fluctuation is not too volatile at this time. Calculation of the real value of SVENSKA CELLULO B is based on 3 months time horizon. Increasing SVENSKA CELLULO's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
SVENSKA CELLULO's intrinsic value may or may not be the same as its current market price of 11.78, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  11.78 Real  12.13 Hype  11.78
The intrinsic value of SVENSKA CELLULO's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence SVENSKA CELLULO's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
12.13
Real Value
13.53
Upside
Estimating the potential upside or downside of SVENSKA CELLULO B helps investors to forecast how SVENSKA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SVENSKA CELLULO more accurately as focusing exclusively on SVENSKA CELLULO's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
10.3811.7813.18
Details

SVENSKA CELLULO Total Value Analysis

SVENSKA CELLULO B is at this time anticipated to have takeover price of 8.91 B with market capitalization of 9.37 B, debt of 8.58 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the SVENSKA CELLULO fundamentals before making investing decisions based on enterprise value of the company

SVENSKA CELLULO Investor Information

About 65.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.08. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. SVENSKA CELLULO B last dividend was issued on the 31st of March 2023. The entity had 3:1 split on the 7th of May 2007. Based on the analysis of SVENSKA CELLULO's profitability, liquidity, and operating efficiency, SVENSKA CELLULO B is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

SVENSKA CELLULO Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. SVENSKA CELLULO has an asset utilization ratio of 15.92 percent. This implies that the Company is making USD0.16 for each dollar of assets. An increasing asset utilization means that SVENSKA CELLULO B is more efficient with each dollar of assets it utilizes for everyday operations.

SVENSKA CELLULO Ownership Allocation

SVENSKA CELLULO B shows a total of 637.76 Million outstanding shares. Over half of SVENSKA CELLULO's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Therefore, these institutions are subject to different rules and regulations than regular investors in SVENSKA CELLULO B. Please watch out for any change in the institutional holdings of SVENSKA CELLULO as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

SVENSKA CELLULO Profitability Analysis

The company reported the revenue of 18.82 B. Net Income was 6.1 B with profit before overhead, payroll, taxes, and interest of 19.3 B.

About SVENSKA CELLULO Valuation

The stock valuation mechanism determines SVENSKA CELLULO's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of SVENSKA CELLULO B based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of SVENSKA CELLULO. We calculate exposure to SVENSKA CELLULO's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SVENSKA CELLULO's related companies.

8 Steps to conduct SVENSKA CELLULO's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates SVENSKA CELLULO's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct SVENSKA CELLULO's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain SVENSKA CELLULO's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine SVENSKA CELLULO's revenue streams: Identify SVENSKA CELLULO's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research SVENSKA CELLULO's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish SVENSKA CELLULO's growth potential: Evaluate SVENSKA CELLULO's management, business model, and growth potential.
  • Determine SVENSKA CELLULO's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate SVENSKA CELLULO's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Additional Tools for SVENSKA Stock Analysis

When running SVENSKA CELLULO's price analysis, check to measure SVENSKA CELLULO's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SVENSKA CELLULO is operating at the current time. Most of SVENSKA CELLULO's value examination focuses on studying past and present price action to predict the probability of SVENSKA CELLULO's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SVENSKA CELLULO's price. Additionally, you may evaluate how the addition of SVENSKA CELLULO to your portfolios can decrease your overall portfolio volatility.